Sign in
Taking people in United StatesPhase 4

Azithromycin Versus Doxycycline in Hospitalized Adult Patients With Community Acquired Pneumonia Treated With Beta-lactams

Key facts

Who runs it
Mayo Clinic
Where
Jacksonville, La Crosse, Mankato, Rochester, and Scottsdale, United StatesSee the 5 sites
Trial code
Status
Recruiting
Phase
Phase 4
People taking part
1,120 people, planned
Started
15 Sept 2025
Expected to end
1 Sept 2031
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Doxycycline
  • Azithromycin
Record updated
24 September 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • All adult patients (>18 years old) admitted with CAP and receiving a beta-lactam antibiotic plus a form of atypical coverage (azithromycin or doxycycline) in the ED within 12 hours of admission

Who cannot take part

  • Allergy or contraindication to the use of either azithromycin or doxycycline (usual clinical practice)
  • Corrected QT prolongation (> 450 ms in men and > 460 ms in women)
  • High clinical suspicion for Legionella pneumonia
  • Antibiotics not for CAP
  • Pregnant women (based on clinical assessment as part of standard of care)
  • Severe CAP as defined by the ATS/IDSA criteria
  • Incarcerated individuals (prisoner)

Where in United States

  • Mayo Clinic in FloridaJacksonville, United StatesContact: Swetha Reddy (principal investigator)Not yet recruiting
  • Mayo Clinic Health System-La CrosseLa Crosse, United StatesContact: Melissa K Myers (principal investigator)Not yet recruiting
  • Mayo Clinic Health System MankatoMankato, United StatesContact: Mohamad El Labban (principal investigator)Not yet recruiting
  • Mayo Clinic in RochesterRochester, United StatesContact: Amy AmsbaughTaking people
  • Mayo Clinic in ArizonaScottsdale, United StatesContact: Cyril Varghese (principal investigator)Not yet recruiting

About the trial

What the trial wants to find out

The purpose of this study is to compare effectiveness and safety of Azithromycin versus Doxycycline in adult patients hospitalized with community acquired pneumonia (CAP) treated with Beta-lactams.

The 2 groups in the trial

  • Doxycycline groupExisting treatment, for comparison

    Subjects hospitalized for community acquired pneumonia will receive standard of care treatment with Doxycycline

    Treatment: Doxycycline

  • Azithromycin groupExisting treatment, for comparison

    Subjects hospitalized for community acquired pneumonia will receive standard of care treatment with Azithromycin

    Treatment: Azithromycin

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
24 September 2026